Cannabis Sativa, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 04:03 pm
Share
Cannabis Sativa, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 721,095 compared to USD 151,063 a year ago. Operating loss was USD 458,346 compared to USD 538,801 a year ago. Net loss was USD 490,106 compared to USD 510,958 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago. For the half year, sales was USD 1.214 million compared to USD 251,345 a year ago. Operating loss was USD 1.131 million compared to USD 1.276 million a year ago. Net loss was USD 1.106 million compared to USD 1.233 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.06 a year ago.
Cannabis Sativa, Inc. is engaged in telehealth through its 51% owned subsidiary and the licensing of cannabis-related intellectual property (IP), marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. It operates through various subsidiaries, including PrestoCorp, Inc. (PrestoCorp), Wild Earth Naturals, Inc., Kubby Patent and Licenses Limited Liability Company, Hi Brands, International, Inc., Eden Holdings LLC, and iBudtender, Inc., GK Manufacturing and Packaging, Inc. PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoCorp uses video conferencing technology to provide a safe and confidential forum for the doctor patient interview in accordance with state regulations governing issuance of medical marijuana cards. It offers services in California, Nevada, New York, Missouri, and Oklahoma.
CANNABIS SATIVA, INC. 
